SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $333 | -99.9% | 2,568 | -46.0% | 0.22% | -33.0% |
| Q1 2022 | $372,000 | -8.1% | 4,752 | +5.7% | 0.34% | -42.2% |
| Q4 2021 | $405,000 | +289.4% | 4,496 | +502.7% | 0.58% | +453.3% |
| Q3 2020 | $104,000 | -85.0% | 746 | -83.7% | 0.10% | -59.9% |
| Q2 2020 | $694,000 | +298.9% | 4,565 | +156.0% | 0.26% | -7.4% |
| Q1 2020 | $174,000 | -74.9% | 1,783 | -60.9% | 0.28% | -27.6% |
| Q2 2019 | $694,000 | – | 4,565 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |